SEC Tracker
Get the app

Possible new SRTA shares

SRTADilution

Known so far: no new shares from the prospectus covers read · no effective shelf · not yet read: converts, ATM.

Shelf room

  • Room today none, no effective shelf
How this is worked out

Shelf room: none. No shelf registration on EDGAR was declared effective in the last 3 years, so a sale needs a new registration or a private placement. Sources: public float, as of Jun 30, 2025.

What could become new Strata Critical Medical (SRTA) shares: warrants and options and RSUs, each with the 10-Q, 10-K, S-1 or 424B filing it comes from.

SRTA dilution ladder

Every source of new shares on record, from the filings that created it.

89.3M outstanding; up to 103M fully diluted, +15%

  1. Outstandingas of Oct 26, 2026 (10-Q filed Nov 3) · share count on the cover page
    89.3M
  2. Warrants010-Q Nov 3, 2026 · securities left out of diluted EPS
    +0
  3. Options and RSUs2.6M options, 11.1M RSUs10-Q Nov 3, 2026 · equity note
    +13.7M

Not stated in the filings we read: an ATM program, convertible notes.

Counts, sizes and prices as stated in each filing; the fully diluted count is arithmetic on them. Dollars become shares only at a price a filing states. Not advice.

Financing terms to know

None found in filings since Nov 3, 2026.

Each term is quoted from the exhibit it comes from; numbers are as stated in the filing. A flag describes a financing term. It is not investment advice.

Shares outstanding

89.3M

Mar 2025 to Oct 2026: from 79.7M to 89.3M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.